We are live on ! Find out more
EXEL icon

Exelixis

339 hedge funds and large institutions have $4.2B invested in Exelixis in 2019 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 121 increasing their positions, 126 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% more call options, than puts

Call options by funds: $64.1M | Put options by funds: $32.8M

0.39% less ownership

Funds ownership: 78.74%78.35% (-0.39%)

4% less repeat investments, than reductions

Existing positions increased: 121 | Existing positions reduced: 126

2% less funds holding

Funds holding: 346339 (-7)

14% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 42

17% less capital invested

Capital invested by funds: $5.08B → $4.2B (-$881M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
339
Holders Change
-7
Holders Change %
-2.02%
% of All Funds
7.43%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
36
Increased
121
Reduced
126
Closed
42
Calls
$64.1M
Puts
$32.8M
Net Calls
+$31.3M
Net Calls Change
+$2.14M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$544M +$1.04M +51,333 +0.2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$497M +$6.67M +329,649 +1%
MG
3
Meditor Group
Bermuda
$265M
Renaissance Technologies
4
Renaissance Technologies
New York
$263M +$28.2M +1,395,123 +10%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$229M -$70.3M -3,473,876 -21%
AQR Capital Management
6
AQR Capital Management
Connecticut
$219M -$26.5M -1,310,066 -10%
State Street
7
State Street
Massachusetts
$185M +$6.03M +298,036 +3%
JP Morgan Chase
8
JP Morgan Chase
New York
$144M +$3.84M +189,755 +2%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$114M +$6.11M +302,089 +5%
Goldman Sachs
10
Goldman Sachs
New York
$93.5M +$6.34M +313,484 +6%
AL
11
AJO LP
Pennsylvania
$72.4M +$69.7M +3,441,790 +527%
First Trust Advisors
12
First Trust Advisors
Illinois
$71.2M -$37.2M -1,840,431 -31%
O
13
OrbiMed
New York
$69.2M
BG
14
Bellevue Group
Switzerland
$68.2M -$407K -20,100 -0.5%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$66.5M -$414K -20,457 -0.5%
FCM
16
Frontier Capital Management
Massachusetts
$63.5M +$11.2M +553,150 +18%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$59.7M +$829K +40,952 +1%
N
18
Nuveen
North Carolina
$55.6M +$18.8M +931,113 +42%
Norges Bank
19
Norges Bank
Norway
$53.5M +$2.77M +136,923 +5%
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$53.5M +$6.56M +324,174 +12%
Fiera Capital (Canada)
21
Fiera Capital (Canada)
Quebec, Canada
$52.4M -$2.01M -99,392 -3%
Northern Trust
22
Northern Trust
Illinois
$41.7M -$1.47M -72,480 -3%
Prudential Financial
23
Prudential Financial
New Jersey
$37.5M +$8.3M +409,909 +24%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$36.9M +$576K +28,461 +1%
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$35.2M -$12M -592,482 -23%

EXEL Hedge Fund Activity: Q3 2019 in Review

339 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q3 2019, worth a combined $4.2B — down 17% from $5.08B a quarter earlier.

Sellers outnumbered buyers: 42 funds closed out of EXEL and 36 opened new positions — a net loss of 6 holders — while 126 trimmed existing stakes and 121 added.

The largest buyer was AJO LP, adding an estimated $69.7M. The largest seller was Fidelity Investments, cutting an estimated $70.3M.

  • 339 institutional investors held Exelixis (EXEL) as of Q3 2019, down from 346 in Q2 2019.
  • Funds reported $4.2B of Exelixis stock for Q3 2019, down 17% quarter-over-quarter.
  • 36 funds opened new Exelixis positions in Q3 2019 and 42 closed out, a net change of -6 holders.
  • The largest Exelixis buyer in Q3 2019 was AJO LP, an estimated $69.7M added.
  • The largest Exelixis seller in Q3 2019 was Fidelity Investments, an estimated $70.3M sold.

Based on aggregated 13F filings for Q3 2019.